Peak-Muscle.com  

Welcome to the Peak-Muscle.com forums.

You are currently viewing our boards as a guest which gives you limited access to view most discussions and access our other features. Come join us in on one of the best online fitness communities. We have 16,000 members that are likeminded towards a fitness, bodybuilding lifestyle. Registration is free and only takes but a few minutes. By joining our free community you will have access to communicate privately with other members (PM), respond to polls, upload content and access many other special features. You will be able to create threads to discuss and or create a fitness regimen. Or just bounce ideas off of some very knowledgeable members. So don't miss out. Registration is fast, simple and absolutely free so please, join our community today!

Register FAQ Members List Calendar Arcade Mark Forums Read
Go Back   Peak-Muscle.com > Bodybuilding and Fitness Discussion > Over 50 and beyond.
User Name
Password

Reply
 
Thread Tools Display Modes
Old 08-08-2017, 01:48 PM   #1
liftsiron
Administrator
 
liftsiron's Avatar
 

Join Date: Nov 2003
Location: Cimmeria
Posts: 18,386
liftsiron has a brilliant futureliftsiron has a brilliant futureliftsiron has a brilliant futureliftsiron has a brilliant futureliftsiron has a brilliant futureliftsiron has a brilliant futureliftsiron has a brilliant futureliftsiron has a brilliant futureliftsiron has a brilliant futureliftsiron has a brilliant futureliftsiron has a brilliant future
Benefits of Long-Term Testosterone Treatment:

US National Library of Medicine National Institutes of Health



Format: Abstract

Send to
J Sex Med. 2017 Aug 3. pii: S1743-6095(17)31339-5. doi: 10.1016/j.jsxm.2017.07.004.


Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME).
Rosen RC1, Wu F2, Behre HM3, Porst H4, Meuleman EJH5, Maggi M6, Romero-Otero J7, Martinez-Salamanca JI8, Jones TH9, Debruyne FMJ10, Kurth KH11, Hackett GI12, Quinton R13, Stroberg P14, Reisman Y15, Pescatori ES16, Morales A17, Bassas L18, Cruz N19, Cunningham GR20, Wheaton OA21; RHYME Investigators.
Collaborators (25)
Author information
Abstract
BACKGROUND:

The benefits and risks of long-term testosterone administration have been a topic of much scientific and regulatory interest in recent years.
AIM:

To assess long-term quality of life (QOL) and sexual function benefits of testosterone replacement therapy (TRT) prospectively in a diverse, multinational cohort of men with hypogonadism.
METHODS:

A multinational patient registry was used to assess long-term changes associated with TRT in middle-age and older men with hypogonadism. Comprehensive evaluations were conducted at 6, 12, 24, and 36 months after enrollment into the registry.
OUTCOMES:

QOL and sexual function were evaluated by validated measures, including the Aging Males' Symptom (AMS) Scale and the International Index of Erectile Function (IIEF).
RESULTS:

A total of 999 previously untreated men with hypogonadism were enrolled at 25 European centers, 750 of whom received TRT at at least one visit during the period of observation. Patients on TRT reported rapid and sustained improvements in QOL, with fewer sexual, psychological, and somatic symptoms. Modest improvements in QOL and sexual function, including erectile function, also were noted in RHYME patients not on TRT, although treated patients showed consistently greater benefit over time in all symptom domains compared with untreated patients. AMS total scores for patients on TRT were 32.8 (95% confidence interval = 31.3-34.4) compared with 36.6 (95% confidence interval = 34.8-38.5) for untreated patients (P < .001). Small but significant improvements in IIEF scores over time also were noted with TRT. Approximately 25% of treated and untreated men also used phosphodiesterase type 5 inhibitors, with notable differences in the frequency of phosphodiesterase type 5 inhibitor prescription use according to physician specialty and geographic site location.
CLINICAL IMPLICATIONS:

TRT-related benefits in QOL and sexual function are well maintained for up to 36 months after initiation of treatment.
STRENGTHS AND LIMITATIONS:

The major strengths are the large, diverse patient population being treated in multidisciplinary clinical settings. The major limitation is the frequency of switching from one formulation to another.
CONCLUSION:

Overall, we confirmed the broad and sustained benefits of TRT across major QOL dimensions, including sexual, somatic, and psychological health, which were sustained over 36 months in our treatment cohort. Rosen RC, Wu F, Behre H, et al. Quality of Life and Sexual Function Benefits Effects of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME). J Sex Med 2017;XX:XXX-XXX.

Copyright © 2017 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.
KEYWORDS:

Hypogonadism; Phosphodiesterase Type 5 Inhibitors; Quality of Life; Sexual Function; Testosterone Replacement Therapy

PMID:
28781213
DOI:
10.1016/j.jsxm.2017.07.004
__________________
ADMIN/OWNER@Peak-Muscle
liftsiron is offline   Reply With Quote
Reply

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT -5. The time now is 03:46 PM.


Powered by: vBulletin Version 3.8.11
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.